NASDAQ Companies

Topline data showed no significant differences in the primary and secondary endpoints when comparing lenabasum to placebo, both added to background drug […]

– FDA Breakthrough Designation for CIN Indication: Plinabulin for Concurrent Administration with Myelosuppressive Chemotherapeutic Regimens in Patients with Non-Myeloid Malignancies […]

HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Rosehill Resources Inc. (“RRI”) and Rosehill Operating Company, LLC (“Rosehill Operating” and together […]

CAMBRIDGE, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]

HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced […]

SAN FRANCISCO, Sept. 08, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced the appointment of Percy Carter, MBA, PhD, […]

REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]

– Company Demonstrates Initial Comparability Between TARA-002 and OK-432, Advancing to Final GMP Comparability Runs –– Reaches Alignment with FDA […]

NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

LAFAYETTE, La., Sept. 08, 2020 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting […]